FendX Completes Pilot Manufacturing Phase and Prepares to Advance to Real-World Assessment of REPELWRAP(TM) Film
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) has successfully completed its pilot manufacturing phase for REPELWRAP™ film in collaboration with Dunmore International Inc. The company is now advancing to real-world assessment of the film's repelling effectiveness at various test venues. This marks a important step towards finalizing the product for commercial production.
Dr. Carolyn Myers, CEO of FendX, expressed excitement about this milestone, emphasizing the importance of real-world testing in providing valuable insights into the film's performance. The company acknowledges the significant contributions of Dunmore International Corp. and McMaster University in reaching this stage of development.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) ha completato con successo la fase pilota di produzione per il film REPELWRAP™ in collaborazione con Dunmore International Inc. L'azienda sta ora passando alla valutazione nel mondo reale dell'efficacia repellente del film in vari luoghi di prova. Questo segna un importante passo verso la finalizzazione del prodotto per la produzione commerciale.
La Dott.ssa Carolyn Myers, CEO di FendX, ha espresso entusiasmo per questo traguardo, sottolineando l'importanza dei test nel mondo reale per fornire preziose informazioni sulle prestazioni del film. L'azienda riconosce i significativi contributi di Dunmore International Corp. e dell'Università McMaster per aver raggiunto questa fase di sviluppo.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) ha completado con éxito su fase piloto de fabricación para la película REPELWRAP™ en colaboración con Dunmore International Inc. La empresa ahora avanza a la evaluación en el mundo real de la efectividad repelente de la película en varios lugares de prueba. Esto marca un paso importante hacia la finalización del producto para la producción comercial.
La Dra. Carolyn Myers, CEO de FendX, expresó emoción por este hito, enfatizando la importancia de las pruebas en el mundo real para proporcionar información valiosa sobre el rendimiento de la película. La empresa reconoce las contribuciones significativas de Dunmore International Corp. y la Universidad McMaster para alcanzar esta etapa de desarrollo.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D)는 Dunmore International Inc.와 협력하여 REPELWRAP™ 필름의 파일럿 제조 단계를 성공적으로 완료했습니다. 회사는 이제 다양한 시험 장소에서 필름의 반발 효과에 대한 현실 평가로 나아가고 있습니다. 이는 상업 생산을 위한 제품 최종화에 중요한 단계를 의미합니다.
FendX의 CEO인 Carolyn Myers 박사는 이 이정표에 대한 흥분을 표현하며 영화 성능에 대한 가치 있는 통찰력을 제공하는 현실 테스트의 중요성을 강조했습니다. 회사는 이 개발 단계에 도달하는 데 기여한 Dunmore International Corp.와 McMaster University의 중요한 기여를 인정합니다.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) a réussi à compléter sa phase de fabrication pilote pour le film REPELWRAP™ en collaboration avec Dunmore International Inc. L'entreprise passe maintenant à l'évaluation dans le monde réel de l'efficacité répulsive du film dans divers lieux de test. Cela marque une étape importante vers la finalisation du produit pour la production commerciale.
Le Dr Carolyn Myers, PDG de FendX, a exprimé son enthousiasme pour cette étape majeure, soulignant l'importance des tests dans le monde réel pour fournir des informations précieuses sur les performances du film. L'entreprise reconnaît les contributions significatives de Dunmore International Corp. et de l'Université McMaster pour avoir atteint cette étape de développement.
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) hat die Pilotproduktionsphase erfolgreich abgeschlossen für den REPELWRAP™ Film in Zusammenarbeit mit Dunmore International Inc. Das Unternehmen geht nun zur realen Bewertung der Abwehrfähigkeit des Films an verschiedenen Testorten über. Dies stellt einen wichtigen Schritt zur Finalisierung des Produkts für die kommerzielle Produktion dar.
Dr. Carolyn Myers, CEO von FendX, äußerte ihre Begeisterung über diesen Meilenstein und betonte die Bedeutung von Tests in der realen Welt, um wertvolle Einblicke in die Leistung des Films zu gewinnen. Das Unternehmen erkennt die bedeutenden Beiträge von Dunmore International Corp. und der McMaster University an, die zu dieser Entwicklungsstufe geführt haben.
- Successful completion of pilot manufacturing phase for REPELWRAP™ film
- Advancement to real-world testing phase
- Collaboration with established partners (Dunmore International Corp. and McMaster University)
- None.
Will evaluate the real-world repelling effectiveness of REPELWRAP(TM) film on surfaces at various test venues
Oakville, Ontario--(Newsfile Corp. - September 4, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX") a nanotechnology company developing surface protection coatings, is pleased to announce that it has successfully completed its pilot manufacturing phase with Dunmore International Inc. and is now moving forward to evaluate the effectiveness of REPELWRAP™ film in real-world settings.
Dr. Carolyn Myers, CEO of FendX states, "With the completion of our pilot manufacturing phase of development, we are excited to embark on real-world testing at various announced test sites. This next phase is crucial, as it will provide valuable insights into the film's performance in real-world settings, guiding us towards finalizing the film for ultimate commercial production." Dr. Myers continues, "FendX acknowledges the invaluable collaboration and expertise that Dunmore International Corp. and McMaster University have provided in finalizing the pilot manufacturing phase. Their support has been pivotal in achieving this milestone and we look forward to building off this success."
About Dunmore International Corp.
Dunmore International Corp. ("Dunmore"), a Steel Partners Holdings L.P. (NYSE: SPLP) operating company, is a global manufacturer of engineered coated and laminated films and foils with manufacturing facilities in the U.S. and Germany. Dunmore offers film conversion services such as coating, metallizing, and laminating along with contract film manufacturing and custom film product development. Dunmore services a diverse group of industries including aircraft, spacecraft, photovoltaic, graphic arts & labels, packaging, and insulation. Dunmore is a subsidiary of Steel Partners and is ISO 9001:2015 and OSHA VPP Star certified.
About FendX Technologies Inc.
FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
ON BEHALF OF THE COMPANY
"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director
Contacts:
Dr. Carolyn Myers, CEO and Director
1-800-344-9868
investor@fendxtech.com
For more information, please visit https://fendxtech.com/ and the Company's profile on SEDAR+ at www.sedarplus.ca.
Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding the Company's plans to embark on real-world testing on surfaces at various test sites and the timing of such testing and expectation of benefits, insights and results from testing; statements regarding finalizing the film for ultimate commercial production scale-up and commercialization; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors should change.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222042
FAQ
What is the current development stage of FendX's REPELWRAP™ film?
Who are FendX's key partners in developing REPELWRAP™ film?
What is the significance of the real-world testing phase for FDXTF stock?
When did FendX Technologies (FDXTF) announce the completion of its pilot manufacturing phase?
